共 63 条
[1]
Holdaway IM(2004)Factors influencing mortality in acromegaly J Clin Endocrinol Metab 89 667-674
[2]
Rajasoorya RC(2008)Mortality in acromegaly: a metaanalysis J Clin Endocrinol Metab 93 61-67
[3]
Gamble GD(2012)Predictors of morbidity and mortality in acromegaly: an Italian survey Eur J Endocrinol 167 189-198
[4]
Dekkers OM(2014)Acromegaly: an endocrine society clinical practice guideline J Clin Endocrinol Metab 99 3933-3951
[5]
Biermasz NR(2006)Medical progress: acromegaly N Engl J Med 355 2558-2573
[6]
Pereira AM(2002)Somatostatin analogs in acromegaly J Clin Endocrinol Metab 87 3013-3018
[7]
Arosio M(1992)Somatostatin analog induces insulin-like growth factor binding protein-1 (IGFBP-1) expression in human hepatoma cells Endocrinology 131 2479-2481
[8]
Reimondo G(2009)Pituitary-independent effect of octreotide on IGF1 generation Eur J Endocrinol 160 543-548
[9]
Malchiodi E(2006)Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2 Endocr Relat Cancer 13 955-962
[10]
Katznelson L(2013)Somatostatin receptors: from signaling to clinical practice Front Neuroendocrinol 34 228-252